收费全文 | 4696篇 |
免费 | 249篇 |
国内免费 | 17篇 |
耳鼻咽喉 | 13篇 |
儿科学 | 53篇 |
妇产科学 | 65篇 |
基础医学 | 497篇 |
口腔科学 | 82篇 |
临床医学 | 586篇 |
内科学 | 1426篇 |
皮肤病学 | 53篇 |
神经病学 | 572篇 |
特种医学 | 90篇 |
外科学 | 417篇 |
综合类 | 14篇 |
预防医学 | 438篇 |
眼科学 | 33篇 |
药学 | 349篇 |
中国医学 | 3篇 |
肿瘤学 | 271篇 |
2023年 | 21篇 |
2022年 | 29篇 |
2021年 | 149篇 |
2020年 | 92篇 |
2019年 | 156篇 |
2018年 | 197篇 |
2017年 | 118篇 |
2016年 | 116篇 |
2015年 | 126篇 |
2014年 | 217篇 |
2013年 | 261篇 |
2012年 | 414篇 |
2011年 | 429篇 |
2010年 | 262篇 |
2009年 | 212篇 |
2008年 | 322篇 |
2007年 | 299篇 |
2006年 | 311篇 |
2005年 | 284篇 |
2004年 | 258篇 |
2003年 | 225篇 |
2002年 | 199篇 |
2001年 | 22篇 |
2000年 | 19篇 |
1999年 | 29篇 |
1998年 | 27篇 |
1997年 | 23篇 |
1996年 | 19篇 |
1995年 | 27篇 |
1994年 | 18篇 |
1993年 | 7篇 |
1992年 | 9篇 |
1991年 | 10篇 |
1990年 | 11篇 |
1989年 | 5篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 6篇 |
1981年 | 4篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1964年 | 1篇 |
1962年 | 2篇 |
1961年 | 1篇 |
1960年 | 3篇 |
1933年 | 1篇 |
1929年 | 1篇 |
Contrast enhancement (CE) is found in 10–60% of low-grade gliomas. Its prognostic significance is controversial, and its correlation with IDH mutations and 1p/19q codeletion is elusive. The aim of this study is to investigate whether CE is associated with molecular characteristics of low-grade gliomas and uncover its prognostic value.
Materials and methodsAll confirmed histological cases of low-grade gliomas diagnosed at our institution between years 2000–2016 were reviewed (n?=?102). Spinal and brainstem localization, only-biopsied tumours with ring-like enhancement and incomplete medical records were excluded.
ResultsMean age was 42 years (?±?13.9 years), and 63.6% were male. The median follow-up time was 79.8 months. CE was present on 25% of preoperative MRI, and 25% of patients were considered high-risk according to Pignatti score. Most were astrocytomas (67%) and 87.2% were surgically removed. IDH mutation was found in 64.6% of tumour samples, and 18.8% had a 1p/19q codeletion. No subgroup differences were observed according to CE except for presurgical performance status and postoperative chemotherapy. IDH status and 1p/19q codeletion were evenly distributed. On univariate analysis, age, size?>?6 cm, CE, extent of resection, Pignatti score, IDH mutation and 1p/19q codeletion were significantly associated to OS. On multivariate analysis, only CE and IDH status were independently associated to OS. CE remained a significant prognostic factor in IDH-mutant non-codeleted tumours when analysed by tumour subtype.
ConclusionCE in low-grade gliomas provides prognostic information in IDH-mutant non-codeleted tumours, although its meaning remains uncertain in IDH-wildtype gliomas.
相似文献